Aurinia Pharmaceuticals Inc (AUPH)
11.65
+0.44 (+3.93%)
USD |
NASDAQ |
May 19, 16:00
11.66
+0.01 (+0.09%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap: 1.651B for May 19, 2022
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 19, 2022 | 1.651B |
| May 18, 2022 | 1.589B |
| May 17, 2022 | 1.623B |
| May 16, 2022 | 1.558B |
| May 13, 2022 | 1.583B |
| May 12, 2022 | 1.402B |
| May 11, 2022 | 1.358B |
| May 10, 2022 | 1.597B |
| May 09, 2022 | 1.268B |
| May 06, 2022 | 1.440B |
| May 05, 2022 | 1.538B |
| May 04, 2022 | 1.612B |
| May 03, 2022 | 1.576B |
| May 02, 2022 | 1.544B |
| April 29, 2022 | 1.459B |
| April 28, 2022 | 1.491B |
| April 27, 2022 | 1.531B |
| April 26, 2022 | 1.549B |
| April 25, 2022 | 1.614B |
| April 22, 2022 | 1.534B |
| April 21, 2022 | 1.552B |
| April 20, 2022 | 1.634B |
| April 19, 2022 | 1.580B |
| April 18, 2022 | 1.602B |
| April 14, 2022 | 1.680B |
| Date | Value |
|---|---|
| April 13, 2022 | 1.741B |
| April 12, 2022 | 1.644B |
| April 11, 2022 | 1.690B |
| April 08, 2022 | 1.698B |
| April 07, 2022 | 1.718B |
| April 06, 2022 | 1.711B |
| April 05, 2022 | 1.716B |
| April 04, 2022 | 1.779B |
| April 01, 2022 | 1.785B |
| March 31, 2022 | 1.755B |
| March 30, 2022 | 1.755B |
| March 29, 2022 | 1.798B |
| March 28, 2022 | 1.749B |
| March 25, 2022 | 1.764B |
| March 24, 2022 | 1.813B |
| March 23, 2022 | 1.772B |
| March 22, 2022 | 1.771B |
| March 21, 2022 | 1.669B |
| March 18, 2022 | 1.693B |
| March 17, 2022 | 1.646B |
| March 16, 2022 | 1.578B |
| March 15, 2022 | 1.486B |
| March 14, 2022 | 1.424B |
| March 11, 2022 | 1.504B |
| March 10, 2022 | 1.533B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
365.83M
Minimum
Oct 14 2019
4.286B
Maximum
Oct 29 2021
1.242B
Average
631.85M
Median
Jan 11 2019
Market Cap Benchmarks
| Edesa Biotech Inc | 29.22M |
| Lexaria Bioscience Corp | 12.79M |
| Liminal Biosciences Inc | 17.69M |
| Xenon Pharmaceuticals Inc | 1.517B |
| ESSA Pharma Inc | 248.06M |
Market Cap Related Metrics
| PS Ratio | 23.37 |
| PEG Ratio | -0.3753 |
| Price to Book Value | 3.688 |
| Price | 11.65 |
| Earnings Yield | -10.98% |
| PEGY Ratio | -0.3753 |